logo
logo

Unlock more results with a Fundz subscription — Get started today!

Get real-time alerts on funding rounds, executive hires, acquisitions, and more— plus verified contact details and AI-powered outreach to connect faster.
Sign up now to unlock exclusive data and opportunities.

Vernal Biosciences Raises $21 Million To Accelerate Mrna Manufacturing Growth

Vernal Biosciences Raises $21 Million To Accelerate Mrna Manufacturing Growth

06/02/22, 7:00 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/GB.svgcolchester
Money raised
$21 million
Industry
biotechnology
Vernal Biosciences, a technology-leading mRNA manufacturer and formulator of LNP-mRNA, announced today the completion of a $21 million financing to fully integrate its mRNA manufacturing solutions. The round was led by Ampersand Capital Partners and Dynamk Capital, with existing investors Alloy Therapeutics and ATUM participating. The round also included a new investment from Charles River Laboratories, Inc. Vernal offers a complete range of mRNA-related services and products ranging from sequence design and screening support, scaled-down and scaled-up manufacturing of high purity mRNA and LNP-mRNA, platform process development technologies, and ultimately GMP manufacturing.

Company Info

Company
Vernal Biosciences
Location
colchester, england, united kingdom
Additional Info
Vernal BioSciences is pioneering the custom mRNA development process for a variety of applications including vaccine development, gene replacement and more!
G2 High Performer Badge

Never Miss an Opportunity: Your #1 Sales Intelligence Tool

Get lightning-fast updates on funding rounds, executive hires, contract awards, and more—powered by AI-driven insights to help you connect with the right prospects first.

Related people

CH

EH

GH

DH

Sign up to get related executive contact information